Literature DB >> 1924295

Effects of injected Alzheimer beta-amyloid cores in rat brain.

S A Frautschy1, A Baird, G M Cole.   

Abstract

Although amyloid deposits have long been known to accumulate in Alzheimer disease (AD) brain, their origin and significance remain speculative. Because of the lack of an in vivo model where amyloid deposits can be induced, the relationship of the extracellular beta-amyloid deposits to other AD pathology has never been directly investigated. Therefore, we injected SDS-isolated amyloid cores into rat cortex and hippocampus. Similarly isolated lipofuscin fractions from control human brains were injected on the contralateral side. Rats were perfused and brains were examined immunohistochemically at 2 days, 7 days, and 1 month after injection. Alz-50, a monoclonal antibody against abnormally phosphorylated tau proteins, stained neurons along the cortical needle track at 2 but not 7 days after injection of either amyloid or lipofuscin. At 1 month, however, ubiquitin, Alz-50 antigen, and silver-positive structures were observed only in response to amyloid. In 7 of 10 animals, there was considerable neuronal loss in the hippocampal layers. In each instance, these effects were in the immediate vicinity of beta-protein immunoreactive material. Marked neuronal loss was never observed at any time after lipofuscin injection. These results indicate a neuronal response to amyloid. When preparations of mature plaque amyloid isolated from the AD brain are injected into the rat brain, they exert neurotoxic effects and induce antigens found in the AD brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924295      PMCID: PMC52508          DOI: 10.1073/pnas.88.19.8362

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Direct synaptic contacts of medial septal efferents with somatostatin immunoreactive neurons in the rat hippocampus.

Authors:  M Yamano; P G Luiten
Journal:  Brain Res Bull       Date:  1989-06       Impact factor: 4.077

2.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

Authors:  B A Yankner; L R Dawes; S Fisher; L Villa-Komaroff; M L Oster-Granite; R L Neve
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

3.  Intrahippocampal colchicine injection results in spectrin proteolysis.

Authors:  P Seubert; Y Nakagawa; G Ivy; P Vanderklish; M Baudry; G Lynch
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

4.  Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.

Authors:  P Walicke; W M Cowan; N Ueno; A Baird; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  An antiserum against amyloid beta-protein precursor detects a unique peptide in Alzheimer brain.

Authors:  G Cole; E Masliah; T V Huynh; R DeTeresa; R D Terry; C Okuda; T Saitoh
Journal:  Neurosci Lett       Date:  1989-05-22       Impact factor: 3.046

7.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

Authors:  S Itagaki; P L McGeer; H Akiyama; S Zhu; D Selkoe
Journal:  J Neuroimmunol       Date:  1989-10       Impact factor: 3.478

8.  Protease nexin I immunostaining in Alzheimer's disease.

Authors:  D E Rosenblatt; C Geula; M M Mesulam
Journal:  Ann Neurol       Date:  1989-11       Impact factor: 10.422

9.  Cytoskeletal protein pathology and the formation of beta-amyloid fibers in Alzheimer's disease.

Authors:  H M Wisniewski; K Iqbal; C Bancher; D Miller; J Currie
Journal:  Neurobiol Aging       Date:  1989 Sep-Oct       Impact factor: 4.673

10.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

View more
  62 in total

1.  Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats.

Authors:  Gao-Shang Chai; Dong-Xiao Duan; Rong-Hong Ma; Jian-Ying Shen; Hong-Lian Li; Zhi-Wei Ma; Yu Luo; Lu Wang; Xin-Hua Qi; Qun Wang; Jian-Zhi Wang; Zelan Wei; Darrell D Mousseau; Li Wang; Gongping Liu
Journal:  Neurosci Bull       Date:  2014-11-12       Impact factor: 5.203

2.  Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

Authors:  S A Frautschy; G M Cole; A Baird
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 3.  Amyloidosis in aging and Alzheimer's disease.

Authors:  D L Price; L C Walker; L J Martin; S S Sisodia
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

4.  Hsp70 ATPase Modulators as Therapeutics for Alzheimer's and other Neurodegenerative Diseases.

Authors:  Umesh K Jinwal; John Koren; John C O'Leary; Jeffrey R Jones; Jose F Abisambra; Chad A Dickey
Journal:  Mol Cell Pharmacol       Date:  2010-01-01

5.  BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.

Authors:  Masuo Ohno; Sarah L Cole; Marina Yasvoina; Jie Zhao; Martin Citron; Robert Berry; John F Disterhoft; Robert Vassar
Journal:  Neurobiol Dis       Date:  2006-12-20       Impact factor: 5.996

6.  Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology.

Authors:  Jiaping Gu; Erin E Congdon; Einar M Sigurdsson
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

7.  Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons.

Authors:  Gabriela Lorea Godoi; Lisiane de Oliveira Porciúncula; Janaína Fagundes Schulz; Fernanda Neutzling Kaufmann; João Batista da Rocha; Diogo Onofre Gomes de Souza; Gabriele Ghisleni; Hiram Larangeira de Almeida
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

Review 8.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

9.  Protective effects and mechanism of total coptis alkaloids on a beta 25-35 induced learning and memory dysfunction in rats.

Authors:  Zheng-qin Yang; Su-fen Yang; Jun-qing Yang; Qi-xin Zhou; Shao-lin Li
Journal:  Chin J Integr Med       Date:  2007-03       Impact factor: 1.978

Review 10.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.